Describing Dr Robert Califf as “one of the most experienced clinical trialists in the country” with more than 1,200 publications in the peer-reviewed literature, President Biden said he had both the experience and expertise to lead the FDA “during a critical time in our nation’s fight” against the coronavirus pandemic.
With nearly 40 years’ experience as ‘a doctor, researcher, leader and public servant’, Califf is also familiar with the role after leading the agency for a year under Barack Obama.
One possible attraction for the White House is that Califf was easily confirmed in 2016 with strong bi-partisan support in the Senate. The announcement of a nominee had been expected as Woodcock cannot legally continue as acting head without a permanent head being nominated.
